Terumo ROE 2012-2018 | TRUMY

Current and historical return on equity (ROE) values for Terumo (TRUMY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Terumo ROE for the three months ending June 30, 2018 was 0.00%.
Terumo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-06-30 $0.53B $5.51B 10.91%
2017-06-30 $0.40B $4.53B 8.46%
2016-06-30 $0.36B $4.42B 7.29%
2015-06-30 $0.39B $4.82B 7.72%
2015-03-31 $0.36B $5.24B 6.98%
2014-12-31 $0.29B $5.09B 5.68%
2014-09-30 $0.36B $5.15B 7.11%
2014-06-30 $0.33B $4.87B 6.79%
2014-03-31 $0.34B $4.96B 7.02%
2013-12-31 $0.64B $5.11B 12.92%
2013-09-30 $0.59B $4.75B 12.16%
2013-06-30 $0.57B $4.66B 11.86%
2013-03-31 $0.58B $5.30B 12.36%
2012-12-31 $0.34B $4.74B 7.51%
2012-09-30 $0.27B $4.39B 6.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.378B $5.308B
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.416B 28.09
Medtronic (MDT) Ireland $143.383B 20.13
Stryker (SYK) United States $81.532B 28.19
Boston Scientific (BSX) United States $59.201B 28.72
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $31.224B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.323B 18.13
Coloplast (CLPBY) Denmark $26.860B 42.88
Lonza Group Ag (LZAGY) Switzerland $26.257B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.390B 0.00
ResMed (RMD) United States $19.442B 37.07
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.146B 54.39
Canopy Growth (CGC) Canada $9.436B 0.00
Insulet (PODD) United States $9.187B 544.39
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $6.980B 20.81
Haemonetics (HAE) United States $6.855B 51.73
Perrigo (PRGO) Ireland $6.412B 11.81
Aurora Cannabis (ACB) Canada $6.033B 59.30
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.550B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.748B 62.34
ICU Medical (ICUI) United States $3.408B 22.10
NuVasive (NUVA) United States $3.354B 26.74
Hutchison China MediTech (HCM) China $2.694B 0.00
Quidel (QDEL) United States $2.542B 25.24
Agios Pharmaceuticals (AGIO) United States $2.526B 0.00
National Vision Holdings (EYE) United States $2.185B 47.17
Cardiovascular Systems (CSII) United States $1.757B 0.00
Aphria (APHA) $1.569B 0.00
Phibro Animal Health (PAHC) United States $1.321B 19.79
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.030B 23.73
Omeros (OMER) United States $1.004B 0.00
NanoString Technologies (NSTG) United States $0.966B 0.00
PetIQ (PETQ) United States $0.929B 21.95
Lantheus Holdings (LNTH) United States $0.899B 23.64
Eagle Pharmaceuticals (EGRX) United States $0.795B 20.26
Cerus (CERS) United States $0.762B 0.00
MacroGenics (MGNX) United States $0.749B 0.00
Quanterix (QTRX) United States $0.691B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.625B 118.74
LeMaitre Vascular (LMAT) United States $0.618B 36.66
OraSure Technologies (OSUR) United States $0.451B 20.86
Meridian Bioscience (VIVO) United States $0.415B 12.95
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.403B 0.00
United Health Products (UEEC) United States $0.392B 0.00
BioLife Solutions (BLFS) United States $0.391B 128.44
Utah Medical Products (UTMD) United States $0.348B 25.50
Zynex (ZYXI) United States $0.327B 34.76
Owens & Minor (OMI) United States $0.310B 9.28
Bovie Medical (APYX) United States $0.258B 0.00
Vapotherm (VAPO) United States $0.237B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.150B 0.00
Female Health (VERU) United States $0.119B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 21.24
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.012B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00